Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Liver Disease Liver Disease for November/December 2020 Endoscopic intragastric balloon improved NASH parameters, More must reads Liver Disease for September/October 2020 Lusutrombopag found safe, effective for severe thrombocytopenia in patients with hepatocellular carcinoma, Bariatric surgery achieved long-term resolution of NASH without worsening fibrosis, More must readsLiver Disease for July/August 2020 Anti-CD8a, anti-IL-17A antibodies improved immune disruption in mice with history of NASH, Studies eyes risks for poor outcomes in primary sclerosing cholangitis, Model identified heavy drinkers at highest risk of ALD progression, More must readsLiver Disease for May/June 2020 Nucleoside polymers show early promise in HBV, Health care costs nearly doubled for patients with NAFLD, More must readsLiver Disease for March/April 2020 Patients with COVID-19 may face risk for liver injury, More must readsPages1 2 3 4 last »
